Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vanguard Extended Market ETF (NY:VXF)

226.04 +4.40 (+1.99%)
Streaming Delayed Price Updated: 2:47 PM EDT, Apr 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vanguard Extended Market ETF

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
News headline image
Why Is ARTL Stock Soaring Pre-Market Today? ↗
Artelo Biosciences secured a fully-funded study to evaluate the effects of its peripherally selective synthetic cannabinoid, ART27.13, in patients with glaucoma or ocular hypertension. 
Via Stocktwits
Topics Artificial Intelligence
News headline image
OCGN Stock Rallies On Wall Street Optimism For Clinical Pipeline: Retail Awaits New Data ↗
Canaccord has a $12 price target on the stock, representing a potential upside of about 415% from the stock’s closing price on Monday. 
Via Stocktwits
News headline image
Why Is This Micro-Cap Biotech Stock Up 150% Today? ↗
Despite the LNAI stock soaring on Tuesday, the company’s shares are still down more than 93% from the stock’s 52-week high of $7.7. 
Via Stocktwits
Topics Artificial Intelligence Intellectual Property
News headline image
Why Did NUAI Stock Rise After Hours Today? ↗
New Era Energy & Digital said it has appointed Ted Warner as Chief Financial Officer, effective March 16, 2026. 
Via Stocktwits
News headline image
HCWB Stock Soars Pre-Market On Positive Research Results For CAR-T Cell Therapy ↗
HCW Biologics said its proprietary multi-cytokine fusion protein reagent, HCW9206, offers a cost-effective way to generate higher-function CAR-T cells for immunotherapy. 
Via Stocktwits
News headline image
Why Is ULY Stock Up Over 160% After Hours? ↗
Privately held digital driver assistance service provider Agero, Inc. said that it would acquire Urgent.ly for $5.50 per share. 
Via Stocktwits
Topics Government
News headline image
Why Is Blue Owl Board Urging Shareholders To Reject Minority Offer From Cox And Saba? ↗
The company said that it believes the minority offer from Cox and Saba is an attempt to capture value at the expense of OBDC II shareholders. 
Via Stocktwits
News headline image
VELO Stock Rallies More Than 20% On Significant Debt Reduction — Retail Cheers Insider Confidence ↗
Velo3D’s CEO Dr. Arun Jeldi purchased a $5 million promissory note from an existing debt holder and converted the same into common stock at $16.38 per share. 
Via Stocktwits
News headline image
Groupon Stock Fell 11% After Hours – Here’s Why ↗
The company said its revenue was $132.7 million in the fourth quarter 2025, below analyst expectations of $136.7 million, as per data from Fiscal.ai. 
Via Stocktwits
News headline image
QURE Stock Edges Up After Hours As Analyst Flags Reduced Regulatory Uncertainty Following Prasad’s FDA Exit ↗
Mizuho said that Dr. Vinay Prasad’s exit just days after a highly public dispute with uniQure appeared to signal an administration-level desire to restore greater regulatory flexibility in rare disease... 
Via Stocktwits
News headline image
MGNX Closes Up 45% On Wall Street Optimism For Experimental Cancer Therapies ↗
Barclays increased the price target on the stock to $4 from $3 and kept an ‘Overweight’ rating on the shares. 
Via Stocktwits
News headline image
Why Did INKT Stock Surge 70% In Pre-Market Today? ↗
MiNK Therapeutics tied up with an oncology consortium to develop a cell therapy targeting pediatric cancers. 
Via Stocktwits
News headline image
This Overlooked Vanguard ETF Could Quietly Outperform the S&P 500 Over the Next 5 Years ↗
Investors have ridden tech stocks and the S&P 500 for years. But the time for large-caps might finally be coming to an end. 
Via The Motley Fool
Topics Artificial Intelligence ETFs Stocks
News headline image
TRVI Stock Slips After Company Plans Parallel Trials In Lung Disease — Stifel Dismisses Timeline Concerns ↗
The company announced its decision following a meeting with the U.S. Food and Drug Administration. 
Via Stocktwits
News headline image
ANTX Stock Records Biggest Ever Single Day Gain, Surges 500% Over Past Four Sessions – What Triggered This Smashing Rally? ↗
AN2 Therapeutics shares more than doubled in value on Monday after the company announced a private placement to raise about $40 million. 
Via Stocktwits
News headline image
BBAI Shares Climb After Having Declined 25% This Year — Retail Says Buy Now To Triple Your Money ↗
BigBear.ai Holdings posted a 38% decline in Q4 revenue to $27.3 million earlier this week, compared to Wall Street’s estimates of $33.3 million, according to data from Fiscal.ai. 
Via Stocktwits
News headline image
ONDS Stock Jumps 8% Following $6 Million Deal For Its Drone Systems – Retail Sees Validation In Repeat Orders ↗
The company announced multiple orders worth for its counter-drone systems, bringing the total to $26 million in March. 
Via Stocktwits
News headline image
Rumble Stock Is Diving After Hours – What Happened To Q4 Revenue? ↗
The decline in Q4 revenue was attributable to a decrease in Audience Monetization revenues and lower Other Initiatives revenues. The revenue was in line with analyst expectations, per Fiscal.ai. 
Via Stocktwits
News headline image
Owlet Stock Is Down 26% After Hours – How Did The Company’s Q4 Results Fare? ↗
Owlet said that for the first quarter of 2026, it expects revenue in the range of $20 to $21 million. The forecast was significantly lower than Wall Street expectations of $26.2 million. 
Via Stocktwits
News headline image
EONR Stock Is Rallying On Oil Price Spike – What Does Retail Think? ↗
U.S. crude oil prices jumped beyond $80 per barrel mark and reached a 52-week high according to data from CNBC. 
Via Stocktwits
Topics Energy
News headline image
Why Did OSRH Stock Jump 20% Today? ↗
The company received an additional 180-day extension from Nasdaq to regain compliance after receiving an initial notice on Sept. 9, 2025. 
Via Stocktwits
News headline image
Why Did IBO Stock Surge 65% In Pre-Market Today? ↗
The company announced amendments to agreements related to its planned merger with Dr. Ashley's, including extending the deadline to complete the merger to July 1, 2026. 
Via Stocktwits
Topics Intellectual Property
News headline image
Why Did BTAI Stock Surge 20% In Pre-Market Today? ↗
BioXcel announced positive Phase 2 results for evaluating treatment for opioid withdrawal symptoms. 
Via Stocktwits
News headline image
BIO-key Discloses Orders From A ‘Foreign Defense Ministry’ – But Stock Loses Initial Gains ↗
The company, however, did not disclose the organization's name but stated that it currently supports more than 50,000 licensed users for the ministry. 
Via Stocktwits
News headline image
ASTS Surges Amid Price Target Hikes, Telus Partnership — Here’s Why UBS Is Bullish On The Stock ↗
UBS analyst Christopher Schoell highlighted that AST SpaceMobile’s revenue is expected to multiply as the company’s commercial service launch draws closer. 
Via Stocktwits
News headline image
MBOT Stock Falls As Investors Ponder Impact Of Geopolitical Tensions On Israel-Founded Company ↗
Microbot said on Tuesday that it is not experiencing any disruption in either the U.S. or Israel with all personnel continuing to operate as usual. 
Via Stocktwits
News headline image
ATRA Rises On Pushing For Meeting With FDA On Rare Disease Drug Rejection ↗
FDA refused approval for tabelecleucel in treating patients two years of age and older with Epstein-Barr virus positive post-transplant lymphoproliferative disease earlier this year. 
Via Stocktwits
News headline image
Battalion Oil Stock More Than Doubles — Retail Sees Hormuz Strait Closure As The ‘Worst Case Scenario’ For Oil ↗
Iran’s Revolutionary Guards commander has reportedly said that the Strait of Hormuz is closed, The Guardian reported. citing Iranian state media. 
Via Stocktwits
News headline image
AARD Stock Slumps 54% Pre-Market – Here’s Why Analysts Are Not ‘Comfortable’ With The Suspension Of A Key Phase 3 Trial ↗
Aardvark Therapeutics shares saw brokerage downgrades after the company paused its Phase 3 trial to treat hyperphagia in patients with Prader-Willi syndrome. 
Via Stocktwits
News headline image
Hawaiian Electric Shares Are Higher Today – Know Why ↗
The company said that its fourth quarter 2025 net income was $40 million, or $0.23 per share, compared to a net loss of $68 million, or $0.40 per share in 2024. 
Via Stocktwits
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.